Gynaecologic Oncology
January 2015
This bulletin covers aspects of gynaecological cancers and should be of interest to multidisciplinary
teams working in this area.
Sections can include:
 Combined Modality Therapies
 Drug Therapy
 Pathology, Staging, Polymorphisms & Biomarkers
 Prognosis, Survival & Risk Factors
 Radiotherapy & Imaging
 Supportive Care & Symptom Management
 Surgery
Many of the following articles are available online via the NHS Scotland Knowledge Network.
Please use the links where provided and your ATHENS password. A complete list of
available online journals and registration for ATHENS can be found at
www.knowledge.scot.nhs.uk/
If the article you require is not available via the NHS Scotland Knowledge Network and you
would like to request a print copy, please submit your request online at
www.quest.scot.nhs.uk
This bulletin contains a selection of material gathered from a search of the evidence base, and is
not intended to be comprehensive. Professional judgment should be exercised when appraising
the material. The Library takes no responsibility for the wording, content and accuracy of the
information supplied, which has been extracted in good faith from reputable sources. NHSGGC is
not responsible for the content of external internet sites.
Compiled by:
Kirsty Coltart
Subject Librarian
Beatson West of Scotland Cancer Centre
0141 301 7285, kirsty.coltart@ggc.scot.nhs.uk
1
Gynaecologic Oncology, January 2015
Kirsty Coltart, Subject Librarian, NHSGGC Library Network
General
Powell, C.B. (2015). Clinical management of patients at inherited risk for gynecologic
cancer. Current opinion in obstetrics & gynecology 27,1:14-22.
Ray-Coquard I, Pujade-Lauraine E and Ledermann JA. (2015). New clinical research
strategies for rare gynecologic malignancies. Current opinion in obstetrics & gynecology
27,1:53-57.
Combined Modality Therapies
Ferrandina G, Gambacorta A, Gallotta V, et al. (2014). Chemoradiation with concomitant
boosts followed by radical surgery in locally advanced cervical cancer: long-term results
of the ROMA-2 prospective phase 2 study. International journal of radiation oncology,
biology, physics 90,4:778-785.
Otsuki A, Watanabe Y, Nomura H, et al. (2015). Paclitaxel and Carboplatin in Patients With
Completely or Optimally Resected Carcinosarcoma of the Uterus: A Phase II Trial by the
Japanese Uterine Sarcoma Group and the Tohoku Gynecologic Cancer Unit. International
Journal of Gynecological Cancer 25,1:92-97.
Rajagopalan MS, Xu KM, Lin JF, et al. (2014). Adoption and impact of concurrent
chemoradiation therapy for vaginal cancer: A National Cancer Data Base (NCDB) study.
Gynecologic oncology 135,3:495-502.
Rose PG, Java JJ, Whitney CW, et al. (2014). Locally advanced adenocarcinoma and
adenosquamous carcinomas of the cervix compared to squamous cell carcinomas of the
cervix in Gynecologic Oncology Group trials of cisplatin-based chemoradiation.
Gynecologic oncology 135,2:208-212.
Sueoka K, Umayahara K, Abe A, et al. (2015). Prognosis for endometrial cancer patients
treated with systematic pelvic and para-aortic lymphadenectomy followed by platinumbased chemotherapy. International Journal of Gynecological Cancer 25,1:81-86.
Tangjitgamol S, Katanyoo K, Laopaiboon M, et al. (2014). Adjuvant chemotherapy after
concurrent chemoradiation for locally advanced cervical cancer. Cochrane Database of
Systematic Reviews 12,010401.
Vargo JA, Boisen MM, Comerci JT, et al. (2014). Neoadjuvant radiotherapy with or without
chemotherapy followed by extrafascial hysterectomy for locally advanced endometrial
cancer clinically extending to the cervix or parametria. Gynecologic oncology 135,2:190195.
Drug & Targeted Therapy
Healthcare Improvement Scotland. NICE Single Technology Appraisal Guidance No 284:
Bevacizumab in combination with paclitaxel and carboplatin for first-line treatment of
advanced ovarian cancer. January 2015.
Kumar A, Hoskins PJ and Tinker AV. (2015). Dose-dense Paclitaxel in Advanced Ovarian
Cancer. Clinical Oncology (Royal College of Radiologists) 27,1:40-47.
Tristram A, Hurt CN, Madden T, et al. (2014). Activity, safety, and feasibility of cidofovir and
2
Gynaecologic Oncology, January 2015
Kirsty Coltart, Subject Librarian, NHSGGC Library Network
imiquimod for treatment of vulval intraepithelial neoplasia (RT(3)VIN): a multicentre,
open-label, randomised, phase 2 trial. Lancet Oncology 15,12:1361-1368.
Tsubamoto H, Takeuchi S, Ito K, et al. (2015). Feasibility and efficacy of intraperitoneal
docetaxel administration as salvage chemotherapy for malignant gynaecological ascites.
Journal of Obstetrics & Gynaecology 35,1:69-73.
Pathology, Staging, Polymorphisms & Biomarkers
Bendifallah S, Canlorbe G, Raimond E, et al. (2015). External validation of nomograms
designed to predict lymphatic dissemination in patients with early-stage endometrioid
endometrial cancer: a multicenter study. American Journal of Obstetrics & Gynecology
212,1:56.e1-56.e7.
Kandukuri SR and Rao J. (2015). FIGO 2013 staging system for ovarian cancer: what is
new in comparison to the 1988 staging system?. Current opinion in obstetrics & gynecology
27,1:48-52.
Kisser A and Zechmeister-Koss I. (2015). A systematic review of p16/Ki-67 immuno-testing
for triage of low grade cervical cytology. BJOG: An International Journal of Obstetrics &
Gynaecology 122,1:64-70.
Kobel M, Madore J, Ramus SJ, et al. (2014). Evidence for a time-dependent association
between FOLR1 expression and survival from ovarian carcinoma: implications for clinical
testing. An Ovarian Tumour Tissue Analysis consortium study. British journal of cancer
111,12:2297-2307.
Pelissier A, Bonneau C, Chereau E, et al. (2014). CA125 kinetic parameters predict optimal
cytoreduction in patients with advanced epithelial ovarian cancer treated with
neoadjuvant chemotherapy. Gynecologic oncology 135,3:542-546.
Schwab CL, English DP, Roque DM, et al. (2014). Past, present and future targets for
immunotherapy in ovarian cancer. Immunotherapy 6,12:1279-1293.
Shim SH, Lee SJ, Kim SO, et al. (2015). Nomogram for predicting incomplete cytoreduction
in advanced ovarian cancer patients. Gynecologic oncology 136,1:30-36.
Sun Y, Hu L, Zheng H, et al. (2015). MiR-506 inhibits multiple targets in the epithelial-tomesenchymal transition network and is associated with good prognosis in epithelial
ovarian cancer. Journal of Pathology 235,1:25-36.
Yang X, Shen F, Hu W, et al. (2015). New ways to successfully target tumor vasculature in
ovarian cancer. Current opinion in obstetrics & gynecology 27,1:58-65.
Prognosis, Survival & Risk Factors
Bjornholt SM, Kjaer SK, Nielsen TS, et al. (2015). Risk for borderline ovarian tumours after
exposure to fertility drugs: results of a population-based cohort study. Human
Reproduction 30,1:222-231.
Frey MK, Philips SR, Jeffries J, et al. (2014). A qualitative study of ovarian cancer survivors'
3
Gynaecologic Oncology, January 2015
Kirsty Coltart, Subject Librarian, NHSGGC Library Network
perceptions of endpoints and goals of care. Gynecologic oncology 135,2:261-265.
Osann K, Hsieh S, Nelson EL, et al. (2014). Factors associated with poor quality of life
among cervical cancer survivors: Implications for clinical care and clinical trials.
Gynecologic oncology 135,2:266-272.
Waterman L and Voss J. (2015). HPV, cervical cancer risks, and barriers to care for lesbian
women. Nurse Practitioner 40,1:46-53.
Win AK, Reece JC and Ryan S. (2015). Family History and Risk of Endometrial Cancer: A
Systematic Review and Meta-analysis. Obstetrics & Gynecology 125,1:89-98.
Radiotherapy & Imaging
Bats AS, Frati A, Froissart M, et al. (2015). Feasibility and performance of
lymphoscintigraphy in sentinel lymph node biopsy for early cervical cancer: results of
the prospective multicenter SENTICOL study. Annals of Nuclear Medicine 29,1:63-70.
Gill BS, Kim H, Houser C, et al. (2014). Image-based three-dimensional conformal
brachytherapy for medically inoperable endometrial carcinoma. Brachytherapy 13,6:542547.
Hou B, Xiang SF, Yao GD, et al. (2014). Diagnostic significance of diffusion-weighted MRI
in patients with cervical cancer: a meta-analysis. Tumour Biology 35,12:11761-11769.
Iati G, Pontoriero A, Mondello S, et al. (2014). Three-dimensional treatment planning for
vaginal cuff brachytherapy: dosimetric effects on organs at risk according to patients
position. Brachytherapy 13,6:568-571.
Vargo JA, Kim H, Choi S, et al. (2014). Extended field intensity modulated radiation therapy
with concomitant boost for lymph node-positive cervical cancer: analysis of regional
control and recurrence patterns in the positron emission tomography/computed
tomography era. International journal of radiation oncology, biology, physics 90,5:1091-1098.
Yap ML, Cuartero J, Yan J, et al. (2014). The Role of Elective Para-aortic Lymph Node
Irradiation in Patients with Locally Advanced Cervical Cancer. Clinical Oncology (Royal
College of Radiologists) 26,12:797-803.
Supportive Care & Symptom Management
Brandner S, Muller-Nordhorn J, Stritter W, et al. (2014). Symptomization and triggering
processes: Ovarian cancer patients' narratives on pre-diagnostic sensation experiences
and the initiation of healthcare seeking. Social science & medicine 119,123-130.
Documet P, Bear TM, Flatt JD, et al. (2015). The association of social support and
education with breast and cervical cancer screening. Health Education & Behavior 42,1:5564.
Farthmann J, Hasenburg A, Weil M, et al. (2015). Quality of life and sexual function in
patients with borderline tumors of the ovary. A substudy of the Arbeitsgemeinschaft
Gynaekologische Onkologie (AGO) study group ROBOT study. Supportive Care in Cancer
4
Gynaecologic Oncology, January 2015
Kirsty Coltart, Subject Librarian, NHSGGC Library Network
23,1:117-123.
Gungorduk K, Ozdemir A, Gokcu M, et al. (2015). Does lubrication of the vaginal speculum
reduce pain during a gynecologic oncology examination?. European Journal of Obstetrics,
Gynecology, & Reproductive Biology 184,84-88.
Guo GH, Yu FY, Wang XJ, et al. (2015). A randomized controlled clinical trial of formalin
for treatment of chronic hemorrhagic radiation proctopathy in cervical carcinoma
patients. Supportive Care in Cancer 23,2:441-446.
Prescott LS, Kidin LM, Downs RL, et al. (2015). Improved compliance with venous
thromboembolism pharmacologic prophylaxis for patients with gynecologic
malignancies hospitalized for nonsurgical indications did not reduce venous
thromboembolism incidence. International Journal of Gynecological Cancer 25,1:152-159.
Rithirangsriroj K, Manchana T and Akkayagorn L. (2015). Efficacy of acupuncture in
prevention of delayed chemotherapy induced nausea and vomiting in gynecologic cancer
patients. Gynecologic oncology 136,1:82-86.
Thornton LM, Cheavens JS, Heitzmann CA, et al. (2014). Test of mindfulness and hope
components in a psychological intervention for women with cancer recurrence. Journal of
Consulting & Clinical Psychology 82,6:1087-1100.
Witt J, Elwyn G, Wood F, et al. (2014). Adapting the coping in deliberation (CODE)
framework: a multi-method approach in the context of familial ovarian cancer risk
management. Patient Education & Counseling 97,2:200-210.
Surgery
Darai E, Dubernard G, Bats AS, et al. (2015). Sentinel node biopsy for the management of
early stage endometrial cancer: Long-term results of the SENTI-ENDO study. Gynecologic
oncology 136,1:54-59.
Gallotta V, Ghezzi F, Vizza E, et al. (2014). Laparoscopic staging of apparent early stage
ovarian cancer: Results of a large, retrospective, multi-institutional series. Gynecologic
oncology 135,3:428-434.
Grimm C, Harter P, Heitz F, et al. (2015). The Sandwich Technique of Diaphragmatic
Stripping or Full-Thickness Resection for Advanced Ovarian Cancer: How to Keep it
Short and Simple. International Journal of Gynecological Cancer 25,1:131-134.
Lee CK, Lord S, Grunewald T, et al. (2015). Impact of secondary cytoreductive surgery on
survival in patients with platinum sensitive recurrent ovarian cancer: Analysis of the
CALYPSO trial. Gynecologic oncology 136,1:18-24.
Liu H, Lawrie TA, Lu D, et al. (2014). Robot-assisted surgery in gynaecology. Cochrane
Database of Systematic Reviews 12,011422.
Prescott LS, Aloia TA, Brown AJ, et al. (2015). Perioperative blood transfusion in
gynecologic oncology surgery: Analysis of the National Surgical Quality Improvement
Program Database. Gynecologic oncology 136,1:65-70.
5
Gynaecologic Oncology, January 2015
Kirsty Coltart, Subject Librarian, NHSGGC Library Network
Please note that the journal articles you are accessing are subject to the terms and conditions
imposed by the publisher, so there will be a limit on the number of articles an individual may
download or print from a single issue of a journal. You can consult your local NHSGGC library with
any queries.
If you have any questions regarding this or any other library services please contact Library staff –
contact details are at the beginning of the bulletin.
Sources used for this bulletin: OVID databases, SIGN, NICE, Healthcare Improvement Scotland
6
Gynaecologic Oncology, January 2015
Kirsty Coltart, Subject Librarian, NHSGGC Library Network